financetom
Business
financetom
/
Business
/
Trump Media & Technology Group (DJT) Shares Plummet 17% In Thursday Pre-Market: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump Media & Technology Group (DJT) Shares Plummet 17% In Thursday Pre-Market: What's Going On?
Nov 7, 2024 11:36 AM

Shares of Trump Media & Technology Group Corp ( DJT ) experienced a sharp decline of 20% during pre-market trading on Thursday, according to Benzinga Pro. This drop comes after a significant surge of 6% the previous day, driven by Donald Trump’s return to the White House for a second term.

The fall is primarily attributed to investors taking profits following the political comeback of President-elect Trump. The company’s stock price decreased by 17.01%, reaching $29.84 in premarket trading.

Meanwhile, U.S. stocks could open in the green on Thursday after a strong post-election rally on Wednesday that saw former President Trump emerge victorious after a long-drawn battle with Joe Biden and Kamala Harris. Futures for the small-cap Russell 2000 index showed a 0.4% increase.

See Also: Trump’s Potential Return To White House Sends Ex-President Linked Phunware Stock Upwards During Pre-Market Hours

The company, which operates Truth Social and is primarily owned by Trump, saw its stock price react to the broader market movements amid Trump’s political resurgence.

The stock has previously hit resistance at the $53.50 level. This resistance level, first encountered in mid-May, has led to a reversal and downward trend.

Read Next:

Elon Musk’s ‘DOGE’ Department Mention Gives Dogecoin Boost To Top Of Daily Gainers: Memecoin Spikes 6%

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Acadia to stop trials of antipsychotic drug after it fails schizophrenia study
Acadia to stop trials of antipsychotic drug after it fails schizophrenia study
Mar 11, 2024
March 11 (Reuters) - Acadia Pharmaceuticals ( ACAD ) said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative symptoms of schizophrenia in a late-stage study. Shares of the California-based company fell 16% in extended trading. The decision comes after two failed attempts to secure regulatory approval...
BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth
BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth
Mar 11, 2024
March 11 (Reuters) - Assure Holdings Corp ( IONM ): * ASSURE HOLDINGS ENTERS INTO AGREEMENT TO SELL CERTAIN OF ITS ASSETS TO MPOWERHEALTH * ASSURE HOLDINGS CORP ( IONM ): TO SELL CERTAIN ASSETS OF ITS IONM BUSINESS TO MPOWERHEALTH FOR UP TO $4.5 MILLION Source text for Eikon: Further company coverage: ...
Atlassian Insider Sold Shares Worth $1,717,897, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,717,897, According to a Recent SEC Filing
Mar 11, 2024
05:26 PM EDT, 03/11/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on March 08, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,717,897. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 115,374 shares of the company, with 115,374 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024002541/xslF345X03/primarydocument.xml Price: 215.82, Change: +0.19, Percent...
Walgreens settles New York charges it inflated prices of infant formula
Walgreens settles New York charges it inflated prices of infant formula
Mar 11, 2024
NEW YORK (Reuters) - Walgreens has settled charges by New York Attorney General Letitia James that the pharmacy chain grossly inflated prices on at least 20 infant formula products in 2022 after a recall by Abbott Labs led to a nationwide shortage. Walgreens did not admit or deny wrongdoing in entering an assurance of discontinuance dated March 7 and made...
Copyright 2023-2025 - www.financetom.com All Rights Reserved